Target Price Playground
BIO.B
$389.98
Swing & Horizon Engine
Need pre-expiry P&L (+3d / +5d), multi-leg ratios, or hedged overlays on BIO.B? Launch with your exact active legs & +20.0% target.
Forward Projection
If price hits $468 by Jan 15
Multi-Option Simulator
Pre-expiry +3d/+5d & Overlays
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Bear Call Credit Spread
Bull Put Credit Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Bet on big move in either direction. Two premiums paid.
๐ฏ Target
1-Click Institutional Target Anchors:
54d from today
โ๏ธ Legs
LONG CALL ยท $390 ยท Jan '27
Qty 1 ยท Premium $19.2 ยท ฮ 0.55
LONG PUT ยท $390 ยท Jan '27
Qty 1 ยท Premium $16.63 ยท ฮ -0.45
P&L at Expiry
Stock (100 sh)
Long Straddle
Now
Target
๐ก Stock vs Options at Target
If BIO.B hits $468 by Jan 15: the long straddle returns +$4,215 (117.7%) on $3,583 risked, vs +$7,800 (20.0%) for 100 shares on $38,998. Options give 5.9ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (54 days out). P&L shown is the value at expiry if BIO.B is at $468.
๐ Projected Return
P&L if BIO.B hits $468 by Jan 15
+$4,215
+117.7% on $3,583 risked
Max Profit
Unlimited
Unlimited on a big move
Max Loss
โ$3,583
Both premiums paid
Break-even
$354.17 / $425.83
Two-sided breakeven range (ยฑ9.19% from spot)
Prob. of Profit at Expiry (PoP)
42.5%
Outside breakeven range ($354.17 โ $425.83)
ยท Touch Target: 8%
30-Day Theta Burn (If Flat)
โ$991
27.7% of entry cost ยท Daily ฮ: $-33.02/day
Net ฮ / ฮ / V
9.15 / -33.02 / 118.9
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| BIO.B Price | Today | +3d (Nov 25) | +7d (Nov 29) | Dec 10 | Dec 28 | Jan 15 (exp) |
|---|---|---|---|---|---|---|
| $312 (-20%) | +$4,054 | +$4,053 | +$4,054 | +$4,069 | +$4,133 | +$4,219 |
| $331 (-15%) | +$2,347 | +$2,323 | +$2,293 | +$2,227 | +$2,195 | +$2,269 |
| $351 (-10%) | +$986 | +$929 | +$854 | +$651 | +$362 | +$319 |
| $370 (-5%) | +$162 | +$77 | -$41 | -$386 | -$1,039 | -$1,631 |
| $382 (-2%) | -$17 | -$114 | -$248 | -$647 | -$1,459 | -$2,801 |
| $390 (0%) โ spot | -$0 | -$101 | -$239 | -$655 | -$1,511 | -$3,581 |
| $398 (+2%) | +$124 | +$23 | -$116 | -$532 | -$1,379 | -$2,805 |
| $409 (+5%) | +$498 | +$401 | +$269 | -$121 | -$869 | -$1,635 |
| $429 (+10%) | +$1,547 | +$1,468 | +$1,361 | +$1,060 | +$575 | +$315 |
| $448 (+15%) | +$2,992 | +$2,933 | +$2,856 | +$2,653 | +$2,385 | +$2,265 |
| $468 (+20%) โ target | +$4,683 | +$4,642 | +$4,590 | +$4,459 | +$4,306 | +$4,215 |
Uses BIO.B's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.